# Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome

> **NCT04308811** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Intrauterine Adhesion

## Interventions

- **BIOLOGICAL:** platelet rich plasma
- **COMBINATION_PRODUCT:** amniotic membrane graft group
- **DEVICE:** Intrauterine balloon

## Key facts

- **NCT ID:** NCT04308811
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-10
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-02-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308811, "Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04308811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*